PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10857765-1	2000	This study aimed to investigate the time-course of the effect of beta2-adrenoceptor stimulation with terbutaline on lipopolysaccharide (LPS)-induced tumour necrosis factor(TNF)-alpha production in rat mesangial cells.	Terbutaline	101-112	adrenoceptor beta 2	Rattus norvegicus	65-83	
10525314-6	1999	TNF-alpha and IL-6 secretion from the cells was altered with beta(2)-adrenoceptor agonists (terbutaline, formoterol) and angiotensin II corresponding to changes of TNF-alpha and IL-6 gene transcription.	Terbutaline	92-103	adrenoceptor beta 2	Rattus norvegicus	61-81	
1347507-0	1992	Hemodynamic effects of terbutaline, a beta 2-adrenoceptor agonist, in conscious rats with secondary biliary cirrhosis.	Terbutaline	23-34	adrenoceptor beta 2	Rattus norvegicus	38-57	
7582479-4	1995	The vasorelaxant potencies of the non-selective beta-adrenoceptor agonist, isoprenaline, the beta 1-adrenoceptor agonist, dobutamine and the beta 2-adrenoceptor agonist, terbutaline were all significantly (P < 0.05) reduced (isoprenaline, ED50 = 265 +/- 31 pmol v. 1.05 +/- 0.42 nmol; dobutamine, ED50 = 294 +/- 67 pmol v. 497 +/- 115 pmol; terbutaline, ED50 = 157 +/- 26 nmol v. 452 +/- 120 nmol) in the presence of the KATP-channel blocker, glibenclamide.	Terbutaline	170-181	adrenoceptor beta 2	Rattus norvegicus	141-160	
8203484-6	1994	Nevertheless, a significant hyperpolarization recorded with terbutaline implied that beta 2-adrenoceptor activation stimulated the Na-K pump at rest.	Terbutaline	60-71	adrenoceptor beta 2	Rattus norvegicus	85-104	
1347507-1	1992	The hemodynamic responses to terbutaline - a selective beta 2-adrenoceptor agonist - were studied in conscious normal rats and in conscious rats with secondary biliary cirrhosis.	Terbutaline	29-40	adrenoceptor beta 2	Rattus norvegicus	55-74	
1963768-8	1990	Furthermore, IP66 (10 nM) also increased, in a significant manner, the amplitude of vasodilatation elicited by the beta 2-adrenoceptor agonist terbutaline, both in rat mesenteric bed and in rat aortic strips.	Terbutaline	143-154	adrenoceptor beta 2	Rattus norvegicus	115-134	
6130811-3	1983	The beta(2)-adrenoceptor agonist, terbutaline (5.0 mg kg(-1)), produced a moderate increase in pineal melatonin content.2 Repeated daily administration of desmethylimipramine (10 mg kg(-1) for 10 days) and maprotiline (10 mg kg(-1) for 10 days), antidepressants predominantly inhibiting noradrenaline (NA) uptake, reduced the isoprenaline-induced increase in pineal melatonin content.	Terbutaline	34-45	adrenoceptor beta 2	Rattus norvegicus	4-24	
2864777-1	1985	Exposure to the beta 2-adrenoceptor agonist terbutaline resulted in a transient stimulation of 45Ca2+ efflux from 45Ca2+ preloaded rat islets perfused in 2 mM Ca2+ and 8.3 mM glucose.	Terbutaline	44-55	adrenoceptor beta 2	Rattus norvegicus	16-35	
2864777-11	1985	The data suggest that the beta 2-adrenoceptor agonist terbutaline has the ability to stimulate insulin secretion in perfused rat islets, requiring extracellular Ca2+ for the full expression of its effects.	Terbutaline	54-65	adrenoceptor beta 2	Rattus norvegicus	26-45	
6149303-7	1984	The selective beta-2 adrenergic receptor agonists, salbutamol (3 X 10(-8) to 3 X 10(-7) M) and terbutaline (10(-7) to 3 X 10(-7) M), caused significantly greater enhancement of the PNS response in preparations from SHR than in those from WKY, whereas the selective beta-1 agonist, dobutamine, caused only inhibition of the PNS responses in preparations from both WKY and SHR.	Terbutaline	95-106	adrenoceptor beta 2	Rattus norvegicus	14-40	
498589-11	1979	Intravenous injection of the selective beta 2-adrenoceptor agonist terbutaline (0.15 mg/kg) restored the systemic arterial pressure to pre-shcok levels and partially raised the cardiac output.	Terbutaline	67-78	adrenoceptor beta 2	Rattus norvegicus	39-58	
24725067-0	2015	The beta2 -adrenoceptor agonist terbutaline recovers rat pharyngeal dilator muscle force decline during severe hypoxia.	Terbutaline	32-43	adrenoceptor beta 2	Rattus norvegicus	4-23	
32592771-8	2020	In conclusion, our work has provided additional quantitative evidence that terbutaline and orciprenaline are weak competitive alpha1-adrenoceptor antagonists, but this additional property is probably not therapeutically important in the clinical treatment of asthma or pulmonary artery hypertension with these more potent beta2-adrenoceptor agonists.	Terbutaline	75-86	adrenoceptor beta 2	Rattus norvegicus	322-340	
226301-5	1979	Both isoprenaline and the selective beta 2-adrenoceptor agonist terbutaline produced a concentration-dependent dilatation of liver sinusoids and slowed erythrocyte flow velocity.	Terbutaline	64-75	adrenoceptor beta 2	Rattus norvegicus	36-55	
30644180-10	2019	Inhalation of the beta2-adrenergic receptor agonist terbutaline improved lung liquid clearance.	Terbutaline	52-63	adrenoceptor beta 2	Rattus norvegicus	18-43	
26426856-9	2015	The beta2-adrenoceptor agonist terbutaline was sufficient to enhance the skin expression of TNF-alpha and IL-1beta and to increase 5-HT-induced scratching in naive rats.	Terbutaline	31-42	adrenoceptor beta 2	Rattus norvegicus	4-22	
24725067-4	2015	AIM: We tested the hypothesis that the beta(2) -adrenoceptor agonist terbutaline improves rat sternohyoid muscle performance especially during hypoxic stress.	Terbutaline	69-80	adrenoceptor beta 2	Rattus norvegicus	39-60	
24725067-9	2015	CONCLUSION: The beta(2) -adrenoceptor agonist terbutaline completely recovers hypoxic depression of upper airway muscle force.	Terbutaline	46-57	adrenoceptor beta 2	Rattus norvegicus	16-37	
25470978-2	2014	We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (beta2-AR)-regulated smooth muscles.	Terbutaline	88-99	adrenoceptor beta 2	Rattus norvegicus	103-129	
24780318-2	2014	We investigated whether an antioxidant (tocopherol) can reduce the effect of terbutaline in beta-2-adrenergic receptor (beta2-AR)-regulated smooth muscles.	Terbutaline	77-88	adrenoceptor beta 2	Rattus norvegicus	92-118	
24780318-2	2014	We investigated whether an antioxidant (tocopherol) can reduce the effect of terbutaline in beta-2-adrenergic receptor (beta2-AR)-regulated smooth muscles.	Terbutaline	77-88	adrenoceptor beta 2	Rattus norvegicus	120-128	
25470978-2	2014	We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (beta2-AR)-regulated smooth muscles.	Terbutaline	88-99	adrenoceptor beta 2	Rattus norvegicus	131-139	
25508605-2	2014	We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (beta2-AR)-regulated smooth muscles.	Terbutaline	88-99	adrenoceptor beta 2	Rattus norvegicus	103-129	
25508605-2	2014	We investigated whether an antioxidant (limonene) can reduce the beta-mimetic effect of terbutaline in beta-2-adrenergic receptor (beta2-AR)-regulated smooth muscles.	Terbutaline	88-99	adrenoceptor beta 2	Rattus norvegicus	131-139	
21752065-3	2011	Clenbuterol is lipophilic and may enter into the intracellular compartment, and because of this, it is likely that clenbuterol will have different effects to classical beta(2)-adrenoceptor agonists such as terbutaline.	Terbutaline	206-217	adrenoceptor beta 2	Rattus norvegicus	168-188	
23718987-10	2013	Based on these in vitro results, we returned to animal testing and observed that the selective beta2-AR antagonist butoxamine reduced nociceptive sensitization in the CRPS model, and that local injection of the selective beta2-AR agonist terbutaline resulted in mechanical allodynia and the production of IL-6 in the cells of the skin.	Terbutaline	238-249	adrenoceptor beta 2	Rattus norvegicus	221-229	
21562317-13	2011	These results indicate that prolonged alveolar hypoxia and treatment with terbutaline impaired beta2AR signaling in alveolar epithelia and in whole lungs, and this signaling was not further impaired by hypoxia.	Terbutaline	74-85	adrenoceptor beta 2	Rattus norvegicus	95-102	
21562317-14	2011	Despite impaired beta2AR signaling, treatment with terbutaline for 4 days prevented the inhibition of alveolar reabsorption caused by in vivo hypoxia.	Terbutaline	51-62	adrenoceptor beta 2	Rattus norvegicus	17-24	
17400887-3	2007	Terbutaline, a beta2-adrenoceptor agonist used to arrest preterm labor, has been associated with increased concordance for autism in dizygotic twins.	Terbutaline	0-11	adrenoceptor beta 2	Rattus norvegicus	15-33	
19429833-7	2009	Propranolol (1 microM) inhibited the rise in NO induced by isoproterenol or the beta(2)-adrenoceptor agonists salbutamol, terbutaline, or fenoterol.	Terbutaline	122-133	adrenoceptor beta 2	Rattus norvegicus	80-100	
12817706-4	2002	Terbutaline (an agonist of beta2-adrenoceptor) and dobutamine (an agonist of beta1-adrenoceptor), both are able to increase intracellular cAMP via activation of adenylate cyclase, were examined in the anesthetized rat with endotoxemia.	Terbutaline	0-11	adrenoceptor beta 2	Rattus norvegicus	27-45	
15159029-6	2004	Peak up-regulation occurred after 30 min with a decline at 1 h. We examined the effects of the specific beta2-adrenergic receptor agonist terbutaline on cytokine production by CEA stimulated rat Kupffer cells.	Terbutaline	138-149	adrenoceptor beta 2	Rattus norvegicus	104-129	
14709345-1	2004	Terbutaline, a selective beta(2)-adrenoceptor (beta(2)AR) agonist, is widely used as a tocolytic to arrest preterm labor but recent studies indicate that excessive betaAR stimulation can alter the expression and function of other neurotransmitter receptors that are essential to fetal/neonatal development.	Terbutaline	0-11	adrenoceptor beta 2	Rattus norvegicus	25-45	
14709345-1	2004	Terbutaline, a selective beta(2)-adrenoceptor (beta(2)AR) agonist, is widely used as a tocolytic to arrest preterm labor but recent studies indicate that excessive betaAR stimulation can alter the expression and function of other neurotransmitter receptors that are essential to fetal/neonatal development.	Terbutaline	0-11	adrenoceptor beta 2	Rattus norvegicus	47-56	
15645294-6	2005	The aim of this study was to detect the effects of the beta(2)-AR agonist terbutaline on nonpregnant and late-pregnant (day 18, 20, 21 or 22) cervices isolated from Sprague-Dawley rats.	Terbutaline	74-85	adrenoceptor beta 2	Rattus norvegicus	55-65	
12603345-6	2003	The aim of the present study was to investigate the uterus relaxant effect of the beta2-adrenoceptor agonists (terbutaline, ritodrin) applied together with the subtype-selective alpha1A-adrenoceptor antagonists (WB 4101, 5-methylurapidil) in an in vitro rat model.	Terbutaline	111-122	adrenoceptor beta 2	Rattus norvegicus	82-100	
12608646-5	2003	These inhibitory actions of terbutaline were prevented by the beta2-adrenoceptor antagonist, ICI 118,551(10(-6) M) but not by an inhibitor of the cAMP-PKA pathway, H-89 (5 x 10(-6) M).	Terbutaline	28-39	adrenoceptor beta 2	Rattus norvegicus	62-80	
11705775-1	2001	Terbutaline, a beta(2)-adrenoceptor (beta(2)-AR) agonist, is a widely used tocolytic that also crosses the placenta to stimulate fetal beta-ARs.	Terbutaline	0-11	adrenoceptor beta 2	Rattus norvegicus	15-35	
11705775-1	2001	Terbutaline, a beta(2)-adrenoceptor (beta(2)-AR) agonist, is a widely used tocolytic that also crosses the placenta to stimulate fetal beta-ARs.	Terbutaline	0-11	adrenoceptor beta 2	Rattus norvegicus	37-47